NCT06317220View on ClinicalTrials.gov

Vedolizumab for the Treatment of Collagenous Gastritis

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

October 31, 2026

Conditions
Collagenous Gastritis
Interventions
BIOLOGICAL

Vedolizumab

Administered over 30 minute infusion at MGH main campus

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Takeda

INDUSTRY

lead

Massachusetts General Hospital

OTHER